BINTRAFUSP ALFA

Search structure
Synonyms:
Status: Phase 3
Entry Type: Protein
Molecule Category: UNKNOWN
UNII: NW9K8C1JN3

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Programmed cell death 1 ligand 1 binding agent PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Thymoma 2 D013945 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Urogenital Neoplasms 2 D014565 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Stomach Neoplasms 1 D013274 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Small Cell Lung Carcinoma 1 D055752 ClinicalTrials
Sarcoma, Kaposi 1 D012514 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Prostatic Neoplasms 1 D011471 ClinicalTrials
Prostatic Neoplasms 1 D011471 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298024
FDA SRS NW9K8C1JN3
CONTENTS